Pharmafile Logo
Pharmafocus logo
Advanced Search
Clinigen logo

Clinigen launches UK managed access program for Takeda’s ixazomib

November 30, 2015
Sales and Marketing Clinigen, Takeda, ixazomib, managed access, multiple myeloma, oncology

Clinigen and Takeda have struck a deal to allow patients in the UK to access the multiple myeloma drug ixazomib …

News
robert_k

Ablynx appoints Robert Zeldin as new chief medical officer

November 30, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Ablynx, Robert Zeldin

Ablynx has appointed Dr Robert Zeldin as chief medical officer (CMO) effective from 1 December 2015.  Dr Zeldin will lead …

Appointment
Almirall logo

Almirall to acquire Poli Group’s skin drugs

November 30, 2015
Sales and Marketing Almirall, Poldi, dermatology, skin, specialty pharma

Almirall has agreed to acquire 100% of the share capital of Poli Group Holding as the Spanish pharma company continues …

News
anastrazole

Pharma company vows to plough profits back into R&D

November 30, 2015
Sales and Marketing Australia, R&D, breast cancer, profits, sales, social enterprise

An Australian pharma company has adopted a social enterprise model in order to be able to donate 100% of its …

News
ASH 2014 meeting

Bayer and Novartis to debut new data at ASH 2015

November 30, 2015
Research and Development, Sales and Marketing American Society of Hematology, Bayer, Conference, Novartis, ash, clinical trials, haematology, oncology

Pharma firms will present clinical trial results for the pipeline drugs they are pinning their 2016 hopes for success on, …

News

SHL Creates Buzz at the 2015 PDA

November 30, 2015
Medical Communications auto injectors, connectivity, pda, pen injectors, pre-filled drug delivery

With a newly designed booth to reflect SHL’s Scandinavian roots, SHL not only brought to this year’s PDA a booth …

News
Press release
computer_industry_entrepreneur_workshop

Promoting diversity in the pharma industry: 10 female pharma rising stars

November 27, 2015
Medical Communications, Sales and Marketing Jobs, Women in pharma, careers, diversity, pharmajobs, recruitment

While some parts of the pharma industry can be dominated by men there are plenty of women making waves in …

Feature
Biogen image

Sobi and Biogen’s haemophilia A treatment EU-approved

November 27, 2015
Sales and Marketing Biogen, elocta, haemophilia a, sobi

Elocta, the haemophilia A treatment developed by the Swedish Orphan Biovitrum (Sobi) and Biogen, has received European Commission approval as …

News
willy_simon

Willy Simon joins Tiziana as non-executive director

November 27, 2015
Research and Development Tiziana life sciences

Tiziana Life Sciences has appointed Willy Simon as a non-executive director who brings the benefit of a long and successful …

Appointment
Sun Pharma logo

Pharma companies look to boost employee retention

November 27, 2015
Medical Communications HR, India, Jobs, recruitment

Drug firms in India are devising novel ‘benching’ models to manage employee turnover. Attrition rates for pharma companies in India …

News
Mylan image

Mylan launches digital adherence programme for heart patients

November 27, 2015
Medical Communications Canada, Mavik, Mylan, pharmacies, trandolapril

Mylan has launched an innovative digital medication adherence and engagement program for patients with high blood pressure. The digital programme, called …

News
michael_linden_300dpi

Pfizer hires new lead for gene therapy research centre

November 26, 2015
Medical Communications, Research and Development Pfizer

Pfizer has hired Professor Michael Linden to lead its new gene therapy research centre in London.  Professor Michael Linden has …

Appointment
praxbind

Boehringer’s Praxbind reversal agent wins EU approval

November 26, 2015
Medical Communications, Research and Development, Sales and Marketing

The European Commission has approved Boehringer Ingelheim’s Praxbind (idarucizumab)- a treatment to rapidly and specifically reverse the anticoagulant effects of …

News
abpi_code_of_practice_2011

Bayer takes on Actavis in ABPI code conduct breach

November 26, 2015
Medical Communications, Sales and Marketing ABPI, Actavis, Bayer, PMCPA

The Prescription Medicines Code of Practice Authority (PMCPA) has ruled in favour of Bayer in a case brought against Actavis. …

News
gsk_manufactures_daraprim_for_the_uk_market

Shkreli Daraprim price U-turn prompts renewed fury

November 26, 2015
Medical Communications, Research and Development, Sales and Marketing

Turing CEO Martin Shkreli has sparked yet more criticism, after going back on a pledge to cut the price of …

News
dna

Companies face mixed fortunes in ultra-orphan approvals

November 26, 2015
Medical Communications, Research and Development BioMarin, Duchenne Muscular Dystrophy, FDA, Genzyme, NICE, ultra-orphan drugs

UK regulator NICE has recommended Vimizin, a drug for a very rare genetic disorder, after the manufacturer and NHS England …

Feature
gsk_boronia_australia

GSK begins Phase III study of sirukumab in giant cell arteritis

November 26, 2015
Business Services, Research and Development, Sales and Marketing GSK, Janssen

GSK today announced it has begun a Phase III study evaluating sirukumab, a human anti-interleukin (IL)-6 monoclonal antibody, for the …

News
shire_image_4

Shire prepares new Baxalta bid

November 26, 2015
Business Services, Sales and Marketing

Following rejection in an earlier bid, it has emerged that Shire is preparing a new takeover offer for US biotech …

News
Chest x ray

Lilly cancer drug gets US approval

November 26, 2015
NSCLC, Portrazza, lilly, lung cancer, necitumumab, non-small cell lung cancer, oncology

Eli Lilly has received FDA approval for its monoclonal antibody Portrazza, in combination with gemcitabine and cisplatin, for patients with …

News
trump_and_clinton

Trump and Clinton hit out at Pfizer over tax inversion plan

November 25, 2015
Sales and Marketing Allergan, Pfizer

Politicians on both sides of the US spectrum have criticised Pfizer over its $160 billion buyout of Allergan and its …

News
The Gateway to Local Adoption Series

Latest content

NICE backs atogepant for acute migraine treatment

June 12, 2026

Survey data highlight challenges in anaphylaxis treatment adherence

June 11, 2026

Hansa Biopharma appoints Fredrik Röök as VP Business Development

June 11, 2026

Sofinnova and AWS collaborate on AI tools for life sciences

June 10, 2026

First European approval given to non-opioid treatment for chronic low back pain

June 9, 2026